Literature DB >> 10649997

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.

D J Hazuda1, P Felock, M Witmer, A Wolfe, K Stillmock, J A Grobler, A Espeseth, L Gabryelski, W Schleif, C Blau, M D Miller.   

Abstract

Integrase is essential for human immunodeficiency virus-type 1 (HIV-1) replication; however, potent inhibition of the isolated enzyme in biochemical assays has not readily translated into antiviral activity in a manner consistent with inhibition of integration. In this report, we describe diketo acid inhibitors of HIV-1 integrase that manifest antiviral activity as a consequence of their effect on integration. The antiviral activity of these compounds is due exclusively to inhibition of one of the two catalytic functions of integrase, strand transfer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10649997     DOI: 10.1126/science.287.5453.646

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  330 in total

1.  Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: application to inhibitor isolation.

Authors:  Y Hwang; D Rhodes; F Bushman
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

2.  Retroviral cDNA integration: stimulation by HMG I family proteins.

Authors:  L Li; K Yoder; M S Hansen; J Olvera; M D Miller; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.

Authors:  K Gao; S L Butler; F Bushman
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

4.  Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA.

Authors:  N Vandegraaff; R Kumar; C J Burrell; P Li
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Scaffold rearrangement of dihydroxypyrimidine inhibitors of HIV integrase: Docking model revisited.

Authors:  Jing Tang; Kasthuraiah Maddali; Yves Pommier; Yuk Y Sham; Zhengqiang Wang
Journal:  Bioorg Med Chem Lett       Date:  2010-04-21       Impact factor: 2.823

6.  HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis.

Authors:  Yonghui Zhang; Kai Li; Wei Zhu; Yi-Liang Liu; Rong Cao; Ran Pang; Eunhae Lee; Jordan Axelson; Mary Hensler; Ke Wang; Katie J Molohon; Yang Wang; Douglas A Mitchell; Victor Nizet; Eric Oldfield
Journal:  ACS Med Chem Lett       Date:  2012-04-03       Impact factor: 4.345

7.  Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection.

Authors:  Tomokazu Yoshinaga; Masanori Kobayashi; Takahiro Seki; Shigeru Miki; Chiaki Wakasa-Morimoto; Akemi Suyama-Kagitani; Shinobu Kawauchi-Miki; Teruhiko Taishi; Takashi Kawasuji; Brian A Johns; Mark R Underwood; Edward P Garvey; Akihiko Sato; Tamio Fujiwara
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

8.  Tautomerism and magnesium chelation of HIV-1 integrase inhibitors: a theoretical study.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  ChemMedChem       Date:  2010-07-05       Impact factor: 3.466

9.  Inhibition of human immunodeficiency virus type 1 isolates by the integrase inhibitor L-731,988, a diketo Acid.

Authors:  Ryan Reinke; Deborah J Lee; W Edward Robinson
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  Quantitative analysis of HIV-1 preintegration complexes.

Authors:  Alan Engelman; Ilker Oztop; Nick Vandegraaff; Nidhanapati K Raghavendra
Journal:  Methods       Date:  2009-02-20       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.